Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study

✍ Scribed by Modi, Satish S.; Lehmann, Robert P.; Walters, Thomas R.; Fong, Raymond; Christie, William C.; Roel, Lawrence; Nethery, David; Sager, Dana; Tsorbatzoglou, Alexis; Philipson, Bo; Traverso, Carlo E.; Reiser, Harvey

• Book ID: 122210852
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 527 KB
• Volume: 40
• Category: Article
• ISSN: 0886-3350
• DOI: 10.1016/j.jcrs.2013.07.042